Vimarsana
Biggest News Aggregation in the World

Page 17 - Presentation Details News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentation Details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentation Details Today - Breaking & Trending Today

Sonnet BioTherapeutics Announces Webcast to Discuss Clinical Data from ... - Vimarsana News

Sonnet BioTherapeutics Announces Webcast to Discuss Clinical Data from ...

Sonnet BioTherapeutics Announces Webcast to Discuss Clinical Data from ...

Bicycle Therapeutics plc: Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting - Vimarsana News

Bicycle Therapeutics plc: Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced

OncoOne Presents Preclinical Data Update from oxMIF-targeting Pipeline at the 2023 AACR Annual Meeting - Vimarsana News

OncoOne Presents Preclinical Data Update from oxMIF-targeting Pipeline at the 2023 AACR Annual Meeting

Next-generation anti-oxMIF antibody ON203 demonstrates anti-tumor effects through tumor cell death and modulation of the immunosuppressive tumor microenvironment in human tumoroids isolated from

UPDATE -- Actuate Therapeutics Announces Poster - Vimarsana News

UPDATE -- Actuate Therapeutics Announces Poster

CHICAGO and FORT WORTH, Texas, April 10, 2023 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company,...

Aviceda Announces 3 Presentations about AVD-104, its Lead Glyco-mimetic Nanoparticle, As a Novel Tre - Vimarsana News

Aviceda Announces 3 Presentations about AVD-104, its Lead Glyco-mimetic Nanoparticle, As a Novel Tre

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aviceda Therapeutics, a private biotech company focused on developing the next generation immuno-modulators by harnessing the power of glycobiology to modulate the innate immune system and alleviate chronic, non-resolving inflammation, today announced their upcoming oral and poster...